NPLIs like Kolibri include nebulizers and soft-mist inhalers developed as an alternative to propellant-based systems. Kolibri ...

Vaxxas announced that it began a multi-center Phase I clinical trial of a vaccine against avian flu using its high-density ...

Dexcom announced today that its G6 continuous glucose monitor (CGM) is being worn by astronauts as part of the Polaris Dawn ...

Orange Biomed announced today that it plans to showcase its microfluidic-based A1C test at the 2024 Diabetes Technology ...

Embecta (Nasdaq:EMBC) announced today that it received FDA 510(k) clearance for its proprietary disposable insulin delivery ...

CorFlow Therapeutics announced today that it raised €44 million ($48.5 million) to support its novel diagnostic and.

CSA Medical announced today that it completed an oversubscribed Series D preferred stock equity financing worth $53 million.

NanoSyrinx, a synthetic biology company developing nanosyringes, announced that it closed a £10 million ($13 million) ...

Elutia (Nasdaq:ELUT) announced the first-ever patient implant of its EluPro drug-eluting biologic envelope cleared by the FDA ...

Beta Bionics announced that it partnered with Abbott (NYSE:ABT) to integrate the company's CGM with its automated insulin ...

Smiths Medical unit issued an urgent field safety notice in Europe to warn of issues with certain medication cassette ...

Abb0tt (NYSE:ABT) announced today that it made its Lingo continuous glucose monitoring system available without a ...